Shanghai Launches New Exchange for High-Tech Companies Including Biopharmas

STIB
Published on: Jun 14, 2019
Author: Amy Liu

China officially launched the Shanghai Exchange’s new Science and Technology Innovation Board (STIB) with news that 119 companies, including 27 biopharmas, have already signed up to IPO on the new exchange. For China, the STIB accomplishes two goals: high tech companies that are not yet profitable can list on a mainland exchange for the first time, and STIB IPOs will be registration-based. That means China regulators will not set the prices of IPOs, nor will they control the schedule and/or number of listing companies.

Source: China Biotoday

Technology